Worth Asset Management »

SPDR S&P Biotech shares owned by Worth Asset Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Worth Asset Management from 13F filings

Historical chart of Worth Asset Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Worth Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Worth Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $440k 4.5k 98.80
2024-06-30 $1.5M 16k 92.71
2024-03-31 $1.2M 13k 94.92
2022-12-31 $20k 240 83.00

More positions owned by Worth Asset Management

Vanguard Value Etf Etf (VTV)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
Spdr Dow Jones Industrial Average Etf Trust Etf (DIA)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Spdr Portfolio S&p 500 Etf Etf (SPLG)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Apple Stock (AAPL)
Neos Enhanced Income 1-3 Month T-bill Etf Etf (CSHI)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Total Bond Market Etf Etf (BND)
Consumer Staples Select Sector Spdr Fund Etf (XLP)
Invesco Nasdaq 100 Etf Etf (QQQM)
Broadcom Stock (AVGO)
3M Stock (MMM)

View all positions for Worth Asset Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Bank of America Corporation
Citigroup
Jane Street
Citadel Advisors
Morgan Stanley
Susquehanna International
NWI Management
Bnp Paribas Arbitrage, Snc
Twin Tree Management
Parallax Volatility Advisers
Wells Fargo & Company
Logos Global Management

View all funds holding SPDR S&P Biotech